Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: An Updated Descriptive Analysis

In this report we examined counts of individuals who received Sinuva or Propel, both of which are mometasone furoate (MF) sinus stents, for the treatment of nasal polyps in the Sentinel Distributed Database (SDD). Additionally, we examined these individuals further on whether they had no record indicating the presence of glaucoma or cataracts in the six months prior to receiving the Sinuva MF sinus stent. This is a follow up to a previous analysis to monitor for uptake of MF sinus stents.

The study period includes data from January 1, 2016 to July 31, 2022. We distributed this query to 14 Sentinel Data Partners on November 17, 2022.